Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Guardant Health Inc shares valued at $5,591 were purchased by Tariq Musa on Jul 17 ’25. At $48.20 per share, Tariq Musa acquired 116 shares.
Also, POTTER MYRTLE S purchased 26 shares, netting a total of over 1,253 in proceeds.
Before that, Talasaz AmirAli had sold 100,000 shares from its account. In a trade valued at $5,087,630, the Co-Chief Executive Officer traded Guardant Health Inc shares for $50.88 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $93.23 million.
As published in their initiating research note from Mizuho on April 10, 2025, Guardant Health Inc [GH] has been an Outperform and the price target has been revised to $55. Analysts at Barclays started covering the stock with ‘”an Overweight”‘ outlook in a report released in late January. As of June 28, 2024, Guggenheim has increased its “Neutral” rating to a “Buy” for GH.
Analyzing GH Stock Performance
On last trading session,, Guardant Health Inc [NASDAQ: GH] plunged -1.11% to $47.28. The stock’s lowest price that day was $47.14, but it reached a high of $49.3 in the same session. During the last five days, there has been a drop of approximately -7.82%. Over the course of the year, Guardant Health Inc shares have jumped approximately 49.90%.
Support And Resistance Levels for Guardant Health Inc (GH)
RSI (Relative Strength Index) is 42.94 on the 14-day chart, showing neutral technical sentiment.
Is Guardant Health Inc subject to short interest?
Stocks of Guardant Health Inc saw a sharp rise in short interest on 2025-06-13 jumping by 0.88 million shares to 10.0 million. Data from Yahoo Finance shows that the short interest on 2025-05-15 was 9.12 million shares. A jump of 8.76% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 5.03 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.03.
Which companies own the most shares of Guardant Health Inc (GH)?
In terms of Guardant Health Inc share price expectations, FactSet research, analysts set an average price target of 61 in the next 12 months, up nearly 27.59% from the previous closing price of $47.81. Analysts anticipate Guardant Health Inc stock to reach 70 by 2025, with the lowest price target being 52. In spite of this, 13 analysts ranked Guardant Health Inc stock as Buy at the end of 2025. On April 24, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and resumed coverage with a $28.
